Published in Hepatology on December 01, 2007
Autoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell Therapy. Can J Gastroenterol Hepatol (2016) 1.39
Access to liver transplantation in the MELD era: role of ethnicity and insurance. Dig Dis Sci (2008) 1.21
Liver transplantation in the ethnic minority population: challenges and prospects. Dig Dis Sci (2009) 0.92
Advances in the current treatment of autoimmune hepatitis. Dig Dis Sci (2012) 0.89
Autoimmune hepatitis in a North American Aboriginal/First Nations population. Can J Gastroenterol (2008) 0.87
Humoral immune response to abnormal MUC1 in subjects with colorectal adenoma and cancer. Mol Immunol (2009) 0.86
Autoimmune hepatitis: Single-center experience of clinical presentation, response to treatment and prognosis in Saudi Arabia. Saudi J Gastroenterol (2010) 0.85
Liver failure as initial presentation of autoimmune hepatitis: clinical characteristics, predictors of response to steroid therapy, and outcomes. Hepatology (2009) 0.84
Current status of therapy in autoimmune liver disease. Therap Adv Gastroenterol (2009) 0.83
Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment. World J Gastroenterol (2009) 0.81
Optimizing management in autoimmune hepatitis with liver failure at initial presentation. World J Gastroenterol (2011) 0.81
Clinical Profile and HLA Typing of Autoimmune Hepatitis From Pakistan. Hepat Mon (2013) 0.81
Management of patients with difficult autoimmune hepatitis. Therap Adv Gastroenterol (2012) 0.79
Global Disparities and Their Implications in the Occurrence and Outcome of Autoimmune Hepatitis. Dig Dis Sci (2017) 0.77
Difference in clinical presentation, immunology profile and treatment response of type 1 autoimmune hepatitis between United Kingdom and Singapore patients. Hepatol Int (2016) 0.77
Management of Difficult Cases of Autoimmune Hepatitis. Curr Gastroenterol Rep (2016) 0.77
Age and ethnicity in cirrhosis. J Investig Med (2014) 0.77
Activated farnesoid X receptor attenuates apoptosis and liver injury in autoimmune hepatitis. Mol Med Rep (2015) 0.75
Auto immune hepatitis. World J Gastroenterol (2016) 0.75
Gender and ethnic differences in the post-liver transplant outcomes of patients with autoimmune hepatitis with acute liver failure at initial presentation: a case-control study. Arch Med Sci (2015) 0.75
Clinical characteristics and corticosteroid therapy in patients with autoimmune-hepatitis-induced liver failure. World J Gastroenterol (2014) 0.75
Outcomes in children who underwent transplantation for autoimmune hepatitis. Liver Transpl (2011) 0.75
Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell (2009) 11.10
Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection. N Engl J Med (2014) 9.25
All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study. Hepatology (2015) 3.96
A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial. Hepatology (2003) 3.09
Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial. Lancet Infect Dis (2012) 2.41
Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. Am J Pathol (2011) 2.41
Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus. AIDS (2005) 2.34
Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology (2002) 2.25
MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology (2009) 2.23
mTOR and P70 S6 kinase expression in primary liver neoplasms. Clin Cancer Res (2004) 2.14
Overexpression of Krüppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenecity. Oncogene (2003) 2.11
Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology (2002) 1.98
The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time. J Clin Oncol (2003) 1.88
Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic. AIDS (2006) 1.82
Racial disparities in the management of hospitalized patients with cirrhosis and complications of portal hypertension: a national study. Hepatology (2007) 1.82
Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection. Clin Infect Dis (2009) 1.80
Caroli's disease and outcomes after liver transplantation. Liver Transpl (2008) 1.78
Acute hepatitis C. Lancet (2008) 1.76
Diagnosis of primary sclerosing cholangitis: a blinded comparative study using magnetic resonance cholangiography and endoscopic retrograde cholangiography. Gastrointest Endosc (2006) 1.74
Hepatitis C is a predictor of acute liver injury among hospitalizations for acetaminophen overdose in the United States: a nationwide analysis. Hepatology (2008) 1.73
Diarrhea in liver transplant recipients: etiology and management. Liver Transpl (2005) 1.71
Progression of liver fibrosis among injection drug users with chronic hepatitis C. Hepatology (2006) 1.63
Prolonged waiting times for liver transplantation in obese patients. Ann Surg (2008) 1.57
Tuberculosis-associated haemophagocytic syndrome. Lancet Infect Dis (2006) 1.55
Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors. Hum Pathol (2013) 1.54
Independent risk factors and natural history of renal dysfunction in liver transplant recipients. Liver Transpl (2003) 1.53
Biliary complications and outcomes of liver transplantation from donors after cardiac death. Liver Transpl (2007) 1.50
Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg (2007) 1.46
Effect of race on outcome of orthotopic liver transplantation: a cohort study. Lancet (2002) 1.45
Relation between vitamin D status and nonalcoholic fatty liver disease in children. J Pediatr Gastroenterol Nutr (2015) 1.44
Utility of bile duct brushings for the early detection of cholangiocarcinoma in patients with primary sclerosing cholangitis. J Clin Gastroenterol (2006) 1.38
Racial disparity in liver disease: Biological, cultural, or socioeconomic factors. Hepatology (2008) 1.36
Severity and correlates of liver disease in hepatitis C virus-infected injection drug users. Hepatology (2002) 1.35
Outcome of liver transplantation in adult recipients: influence of neighborhood income, education, and insurance. Liver Transpl (2004) 1.35
Identification of novel cellular targets in biliary tract cancers using global gene expression technology. Am J Pathol (2003) 1.33
Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma. AJR Am J Roentgenol (2003) 1.31
A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma. J Proteome Res (2008) 1.27
Nationwide increase in hospitalizations and hepatitis C among inpatients with cirrhosis and sequelae of portal hypertension. Clin Gastroenterol Hepatol (2007) 1.25
Use of laser capture microdissection to map hepatitis C virus-positive hepatocytes in human liver. Gastroenterology (2013) 1.23
MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint. Hepatology (2011) 1.22
A proteomic analysis of human bile. Mol Cell Proteomics (2004) 1.20
Prolongation of QTc interval: relationship with etiology and severity of liver disease, mortality and liver transplantation. Liver Int (2003) 1.17
The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection. Hepatology (2005) 1.17
Chitosan-DNA nanoparticles delivered by intrabiliary infusion enhance liver-targeted gene delivery. Int J Nanomedicine (2006) 1.16
Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States. Hum Pathol (2006) 1.16
Relationship of the model for end-stage liver disease (MELD) scale to hepatic encephalopathy, as defined by electroencephalography and neuropsychometric testing, and ascites. Am J Gastroenterol (2003) 1.14
Malignant transformation of hepatic adenomas. Mod Pathol (2008) 1.13
Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus. Liver Transpl (2002) 1.11
Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion. Blood (2002) 1.10
Steroid avoidance in liver transplantation: meta-analysis and meta-regression of randomized trials. Liver Transpl (2008) 1.10
Liver enzyme flares and occult hepatitis B in persons with chronic hepatitis C infection. J Clin Virol (2007) 1.10
Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study. J Gastroenterol Hepatol (2013) 1.08
Methylation regulates hepatitis B viral protein expression. J Infect Dis (2009) 1.07
Outcomes of patients with cirrhosis undergoing non-hepatic surgery: risk assessment and management. World J Gastroenterol (2007) 1.07
Fibrolamellar carcinomas show overexpression of genes in the RAS, MAPK, PIK3, and xenobiotic degradation pathways. Hum Pathol (2007) 1.06
Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus. Liver Transpl (2003) 1.05
Race and comorbid factors predict nonalcoholic fatty liver disease histopathology in severely obese patients. Surg Obes Relat Dis (2006) 1.05
Sympathetic nervous system inhibition increases hepatic progenitors and reduces liver injury. Hepatology (2003) 1.05
Chemoembolization of hepatocellular carcinoma: results of a metaanalysis. Am J Clin Oncol (2003) 1.04
Comprehensive genetic and epigenetic analysis of occult hepatitis B from liver tissue samples. Clin Infect Dis (2008) 1.04
Hepatitis B virus replication induces methylation of both host and viral DNA. J Virol (2010) 1.03
Fibrolamellar carcinomas are positive for CD68. Mod Pathol (2010) 1.03
Unique conformation of cancer autoantigen B23 in hepatoma: a mechanism for specificity in the autoimmune response. Proc Natl Acad Sci U S A (2003) 1.03
Anterior gradient-2 is overexpressed by fibrolamellar carcinomas. Hum Pathol (2008) 1.02
A new alternative for a transjugular intrahepatic portosystemic shunt: EUS-guided creation of an intrahepatic portosystemic shunt (with video). Gastrointest Endosc (2009) 1.02
Short-term postliver transplant survival after the introduction of MELD scores for organ allocation in the United States. Liver Int (2005) 1.01
Complementary and alternative medicine in hepatology: review of the evidence of efficacy. Clin Gastroenterol Hepatol (2007) 1.00
Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3. Gut (2011) 1.00
Post-liver-transplant anemia: etiology and management. Liver Transpl (2004) 1.00
The impact of cirrhosis and portal hypertension on mortality following colorectal surgery: a nationwide, population-based study. Dis Colon Rectum (2009) 1.00
Norepinephrine induces hepatic fibrogenesis in leptin deficient ob/ob mice. Biochem Biophys Res Commun (2003) 0.99
Management of acute hepatitis C. Clin Liver Dis (2010) 0.99
Hepatitis C-associated hepatocellular carcinomas in non-cirrhotic livers. Mod Pathol (2009) 0.99
Mac-2-binding protein is a diagnostic marker for biliary tract carcinoma. Cancer (2004) 0.98
The V599E BRAF mutation is uncommon in biliary tract cancers. Mod Pathol (2004) 0.98
The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation. Transplantation (2002) 0.98
Mortality from hepatocellular and biliary cancers: changing epidemiological trends. Am J Gastroenterol (2002) 0.97
Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study. Biol Blood Marrow Transplant (2003) 0.97
Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC. Am J Gastroenterol (2004) 0.96
Prevalence of transaminase abnormalities in asymptomatic, healthy subjects participating in an executive health-screening program. Dig Dis Sci (2003) 0.96
Noninvasive markers of fibrosis for longitudinal assessment of fibrosis in chronic liver disease: are they ready for prime time? Am J Gastroenterol (2005) 0.96
Twenty years of liver transplantation for Budd-Chiari syndrome: a national registry analysis. Liver Transpl (2007) 0.96
Cryptogenic cirrhosis and NAFLD: are they related? Am J Gastroenterol (2006) 0.95
Epigenetic instability is rare in fibrolamellar carcinomas but common in viral-associated hepatocellular carcinomas. Mod Pathol (2008) 0.95
Endoscopic management of biliary complications after liver transplantation. Clin Liver Dis (2010) 0.94
Uterine tumor resembling ovarian sex cord tumor: report of a case with t(X;6)(p22.3;q23.1) and t(4;18)(q21.1;q21.3). Diagn Mol Pathol (2003) 0.94
Screening for hepatocellular carcinoma. J Vasc Interv Radiol (2002) 0.94
Detection of tumor DNA at the margins of colorectal cancer liver metastasis. Clin Cancer Res (2011) 0.93
Expression of inducible nitric oxide synthase in paired neoplastic and non-neoplastic primary prostate cell cultures and prostatectomy specimen. Urol Oncol (2003) 0.93
Loss of SDHB and NF1 genes in a malignant phyllodes tumor of the breast as detected by oligo-array comparative genomic hybridization. Cancer Genet Cytogenet (2010) 0.93
Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinoma. Mod Pathol (2013) 0.92
Mitochondrial mutations in hepatocellular carcinomas and fibrolamellar carcinomas. Mod Pathol (2010) 0.92
Segmental atrophy of the liver: a distinctive pseudotumor of the liver with variable histologic appearances. Am J Surg Pathol (2011) 0.91
Successful removal of the proximally migrated pancreatic winged stent by using the SpyGlass visualization system. Gastrointest Endosc (2010) 0.91
FibroSURE and FibroScan in relation to treatment response in chronic hepatitis C virus. World J Gastroenterol (2011) 0.90
Successful closure of a chronic refractory gastrocutaneous fistula with a new endoscopic suturing device (with video). Gastrointest Endosc (2011) 0.90
The utility of TIPS in the management of Budd-Chiari syndrome. Ann Surg (2005) 0.90
Laser captured hepatocytes show association of butyrylcholinesterase gene loss and fibrosis progression in hepatitis C-infected drug users. Hepatology (2012) 0.89